HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+15.65%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$219M
AUM Growth
+$219M
(+78%)
Cap. Flow
+$84.3M
Cap. Flow
% of AUM
38.57%
Top 10 Holdings %
Top 10 Hldgs %
33.7%
Holding
163
New
55
Increased
48
Reduced
23
Closed
29
Top Buys
| 1 |
Invesco DB Commodity Index Tracking Fund
DBC
|
$31.6M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$3.49M |
| 3 |
AJRD
Aerojet Rocketdyne Holdings, Inc.
AJRD
|
$3.38M |
| 4 |
TXNM
TXNM Energy, Inc.
TXNM
|
$3.15M |
| 5 |
Indivior
INDV
|
$3.09M |
Top Sells
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$4.25M |
| 2 |
Coupang
CPNG
|
$4.1M |
| 3 |
OSH
Oak Street Health, Inc.
OSH
|
$3.46M |
| 4 |
TEGNA Inc
TGNA
|
$2.44M |
| 5 |
First Horizon
FHN
|
$2.41M |
Sector Composition
| 1 | Healthcare | 46.57% |
| 2 | Technology | 13.44% |
| 3 | Communication Services | 5.29% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Financials | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Xenon Pharmaceuticals
XENE
$2.99B
| $677K | 0.31% |
17,575
-7,765
| -31% | -$299K |
|
102
NOV
NOV
$4.82B
| $675K | 0.31% |
+42,052
| New | +$675K |
|
103
Dropbox
DBX
$7.82B
| $674K | 0.31% |
+25,290
| New | +$674K |
|
104
TSMC
TSM
$1.2T
| $674K | 0.31% |
+6,675
| New | +$674K |
|
105
Teck Resources
TECK
$16.5B
| $672K | 0.31% |
15,962
+6,812
| +74% | +$287K |
|
106
New York Times
NYT
$9.58B
| $663K | 0.3% |
+16,837
| New | +$663K |
|
|
EXE
107
Expand Energy Corporation Common Stock
EXE
$23.1B
| $662K | 0.3% |
7,916
+3,526
| +80% | +$295K |
|
108
Alibaba
BABA
$325B
| $655K | 0.3% |
7,857
+5,197
| +195% | +$433K |
|
109
Warner Music
WMG
$17.3B
| $646K | 0.3% |
+24,779
| New | +$646K |
|
110
Madrigal Pharmaceuticals
MDGL
$9.7B
| $646K | 0.3% |
2,796
| – | – |
|
111
KalVista Pharmaceuticals
KALV
$713M
| $626K | 0.29% |
+69,567
| New | +$626K |
|
112
Pliant Therapeutics
PLRX
$105M
| $617K | 0.28% |
34,035
| – | – |
|
113
Crinetics Pharmaceuticals
CRNX
$3.26B
| $588K | 0.27% |
32,623
-15,622
| -32% | -$282K |
|
114
Sarepta Therapeutics
SRPT
$1.98B
| $573K | 0.26% |
5,005
-2,708
| -35% | -$310K |
|
|
MRTX
115
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $569K | 0.26% |
15,738
| – | – |
|
116
Kura Oncology
KURA
$732M
| $558K | 0.26% |
52,787
+23,545
| +81% | +$249K |
|
117
Constellium
CSTM
$1.93B
| $511K | 0.23% |
+29,694
| New | +$511K |
|
118
Autoliv
ALV
$9.56B
| $497K | 0.23% |
5,844
+3,644
| +166% | +$310K |
|
119
BioCryst Pharmaceuticals
BCRX
$1.74B
| $484K | 0.22% |
+68,725
| New | +$484K |
|
120
Iovance Biotherapeutics
IOVA
$800M
| $468K | 0.21% |
+66,526
| New | +$468K |
|
121
Prothena Corp
PRTA
$452M
| $437K | 0.2% |
6,406
-8,166
| -56% | -$558K |
|
122
Li Auto
LI
$24.4B
| $420K | 0.19% |
+11,966
| New | +$420K |
|
123
Relay Therapeutics
RLAY
$709M
| $404K | 0.19% |
32,197
-97,048
| -75% | -$1.22M |
|
124
Pinduoduo
PDD
$177B
| $403K | 0.18% |
+5,831
| New | +$403K |
|
125
Geron
GERN
$893M
| $394K | 0.18% |
+122,704
| New | +$394K |
|